![Nick Hart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nick Hart
Director/Board Member at ProSpect Pharma, Inc.
Nick Hart active positions
Companies | Position | Start | End |
---|---|---|---|
ProSpect Pharma, Inc.
![]() ProSpect Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services ProSpect Pharma, Inc. provides drug designing services. It develops and markets and uses advanced technologies and products for the Life Science industries, particularly those related to drug design, vaccine development and metabolic studies. The company was founded in 2004 and is headquartered in Baltimore, MD. | Director/Board Member | 30/05/2010 | - |
Career history of Nick Hart
Former positions of Nick Hart
Companies | Position | Start | End |
---|---|---|---|
Hemcon Medical Technologies, Inc.
![]() Hemcon Medical Technologies, Inc. Medical DistributorsDistribution Services Hemcon Medical Technologies, Inc. develops, manufactures, and markets technologies to control bleeding and infection resulting from trauma or surgery. Its solutions include military, emergency and trauma, dental, hemodialysis center, sports medicine, EMS, Cardiac Cath, IR and electrophysiology, wound debridement, occupational healthcare, and wilderness medicine solutions. The company was founded by William Wiesmann, Kenton Gregory, and Simon McCarthy in 2001 and is headquartered in Portland, OR. | Director of Finance/CFO | 23/01/2011 | - |
President | 24/01/2011 | - | |
Neuro3D SA
![]() Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Director of Finance/CFO | - | - |
Statistics
International
United States | 3 |
France | 2 |
Operational
Director of Finance/CFO | 2 |
Director/Board Member | 1 |
President | 1 |
Sectoral
Health Technology | 2 |
Commercial Services | 2 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Neuro3D SA
![]() Neuro3D SA Pharmaceuticals: OtherHealth Technology Neuro3d SA develops pharmaceutical products to treat the central nervous system. Neuro3d has a full pipeline of innovative compounds with new mechanisms of action that have the potential to overcome the limitations of current drug therapies. It leads compound, the atypical antipsychotic ocaperidone, is being investigated in two international double-blind Phase II trials for treatment of schizophrenia. The company was founded in November 2000 and is headquartered in Mulhouse, France. | Health Technology |
ProSpect Pharma, Inc.
![]() ProSpect Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services ProSpect Pharma, Inc. provides drug designing services. It develops and markets and uses advanced technologies and products for the Life Science industries, particularly those related to drug design, vaccine development and metabolic studies. The company was founded in 2004 and is headquartered in Baltimore, MD. | Commercial Services |
Hemcon Medical Technologies, Inc.
![]() Hemcon Medical Technologies, Inc. Medical DistributorsDistribution Services Hemcon Medical Technologies, Inc. develops, manufactures, and markets technologies to control bleeding and infection resulting from trauma or surgery. Its solutions include military, emergency and trauma, dental, hemodialysis center, sports medicine, EMS, Cardiac Cath, IR and electrophysiology, wound debridement, occupational healthcare, and wilderness medicine solutions. The company was founded by William Wiesmann, Kenton Gregory, and Simon McCarthy in 2001 and is headquartered in Portland, OR. | Distribution Services |
- Stock Market
- Insiders
- Nick Hart
- Experience